Over the past decade, most US states and territories began mandating that acute care hospitals report health careassociated infections (HAIs) to their departments of health. Trends in state HAI law enactment and data submission requirements were determined through systematic legal review; state HAI coordinators were contacted to confirm collected data. As of January 31, 2013, 37 US states and territories (71%) had adopted laws requiring HAI data submission, most of which were enacted and became effective in 2006 and 2007. Most states with HAI laws required reporting of central line-associated bloodstream infections in adult intensive care units (92%), and about half required reporting of methicillin-resistant Staphylococcus aureus and Clostridium difficile infections (54% and 51%, respectively). Overall, data submission requirements were found to vary across states. Considering the facility and state resources needed to comply with HAI reporting mandates, future studies should focus on whether these laws have had the desired impact of reducing infection rates.
Health care-associated infections (HAIs) are largely preventable, result in significant morbidity and mortality, and have large attributable costs. 1, 2 Because of the magnitude of the problem and the long-standing use of standardized HAI measurement definitions developed by the Centers for Disease Control and Prevention's (CDC's) National Nosocomial Infections Surveillance System / National Healthcare Safety Network (NHSN), HAI reporting has emerged as an important component in quality care measurement. In the NHSN, each HAI type has specific definitions for surveillance and frequently includes laboratory-confirmed event reporting of the infectious organism. Although these definitions were initially used internally for the purposes of local infection prevention efforts, HAI surveillance data are increasingly being used to compare patient care quality across institutions.
A former survey of state hospital associations found that all 50 US states reported some type of effort to reduce HAIs, 3, 4 with the majority focusing on central lineassociated bloodstream infections (CLABSIs). However, there are other common device-associated infections that are frequently of interest, including catheter-associated urinary tract infections (CAUTIs) and ventilator-associated pneumonia (VAP). Also of increasing concern are infections caused by multidrug-resistant organisms (MDRO), including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci. Clostridium difficile infections are also common HAIs associated with antibiotic use. CLABSI, CAUTI, MRSA, and C difficile infections are among the HAIs indicated on the National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination as being priority areas 5 ; progress toward infection rate reduction and increased adherence to prevention practices are reviewed yearly to achieve 5-year targets.
Over the past decade, the majority of states have legally mandated that hospitals provide HAI data to their state departments of health 6 ; however, a past review found large variation in these mandates in terms of how the data are submitted, whether or not the data are publicly reported, and if facility identifiers are required in the public reports. 7 To the study team's knowledge, no published literature has provided a current, detailed, and systematic review of state mandates in terms of date of enactment, key elements of the mandates (eg, public reporting requirements), and the types of HAI data submission requirements over time. These data are useful to identify trends and allow across-state comparisons. The purpose of this public health law review was to systematically categorize state mandates requiring data submission and public reporting of HAIs among US states and territories. State mandates were evaluated to establish when different elements of the HAI laws were implemented, as well as when data submission requirements for the different types of HAIs began.
Methods
A systematic legal review of state-level statutes and administrative regulations was conducted to determine HAI data submission and public reporting requirements by acute care hospitals. The laws and other administrative requirements as of January 31, 2013, were reviewed for the 50 US states and 2 territories (District of Columbia and Puerto Rico). Lexis Research System databases, online statutory compilations, and administrative regulation databases were utilized for the searches. Variant forms of the key phrase "healthcare-associated infections" were used to locate state requirements; this included "HAI," "healthcare-associated infection," "healthcare-acquired infection," "facility-acquired infection," and "facility-associated infection." State HAI Web sites and other administrative resources also were reviewed to determine the HAI legal requirements of each state.
For states with mandatory data submission, the following information was recorded: date of enactment for the first law mandating HAI data submission (for any HAI); date that the HAI law became effective and enforceable; year that data submission was first legally required for any HAI (ie, when deadlines were imposed); year of state HAI prevention program implementation; requirement of hospitals in states with HAI laws to submit data to the NHSN; and inclusion of public reporting provisions in the HAI law. States considered to have implemented HAI prevention programs included those with formally designated programs as well as those with some form of HAI prevention and reporting efforts but not yet formally designated as a defined program.
Data were collected pertaining to specific HAIsincluding device-associated infections (CLABSI, CAUTI, and VAP) and infections caused by MDROs (MRSA, vancomycin-resistant enterococci, and C difficile). For each infection type, the first year of required data submission in adult intensive care units (ICUs) was determined. Additionally, for those states in which hospitals were required to submit CLABSI data, it was determined whether submission was required in pediatric and/ or neonatal ICUs. Information collected for MDRO infections included laboratory-confirmed event reporting and/or surveillance, as well as for MDRO infections reported in aggregate.
To ensure that the data collected were an accurate representation, state HAI coordinators were contacted via e-mail (ie, individuals responsible for coordinating HAI prevention work within each state). The HAI coordinators were identified through the CDC's statebased HAI prevention Web site (http://www.cdc.gov/ hai/state-based/index.html). For each state, information that had been recorded during the systematic legal review was described, and confirmation was sought from the HAI coordinators. If the information was not correct or if information had not been found, they were asked to provide the correct information. When necessary, follow-up e-mails were sent, or the coordinators were contacted by telephone. Initial e-mails were sent during February 2013, and all responses were received before the end of March 2013. HAI coordinators were not asked to identify relevant legislation, nor were they asked to confirm information about effective dates for HAI laws or public reporting provisions. Descriptive analyses were performed using SAS 9.2 (SAS Institute, Inc., Cary, NC).
Results

Mandatory HAI Data Submission Laws
As of January 31, 2013, 37 of 52 US states and territories (ie, District of Columbia, Puerto Rico) had adopted laws requiring submission of HAI data (Table 1) . HAI coordinators in 32 of 37 states (86%) provided e-mail verification of collected data; data for Georgia, New Hampshire, Nevada, Puerto Rico, and South Carolina were not confirmed. Table 2 shows the years that HAI laws were enacted and became effective for each state. Among states with laws, the majority first enacted those laws in 2006 and 2007 (54% for both years). Similarly, the majority of HAI laws became effective in 2006 and 2007 (52% for both years). The exact dates (ie, month, day) of HAI law enactment or approval could not be determined for Georgia and New Mexico. Among the remaining 35 states for which exact enactment and effective dates could both be determined, laws became effective immediately upon enactment or approval in 15 states (43%), within less than 3 months in 12 states (34%), within 3 to 9 months in 6 states (17%), and after 1 year in 2 states (6%; data not shown).
The largest proportions of states first required HAI data submission in 2008 and implemented state HAI prevention programs in 2009 (Table 2) . Overall, however, most states implemented HAI programs during the same year or before the year that HAI data submission was first required. In 6 states (16%), mandatory HAI data submission requirements predated HAI program implementation (District of Columbia, Florida, Illinois, Maine, Utah, and Vermont). Furthermore, in 7 states (19%), HAI program implementation predated HAI law enactment (Arkansas, Georgia, Hawaii, Indiana, New Mexico, North Carolina, and Tennessee). Hospitals in 31 states (84%) were required to submit HAI data to the NHSN since the time of HAI law enactment or later ( Table 3 ). Instead of reporting to the NHSN, hospitals in the remaining 6 states submitted data to a state entity using the state's HAI reporting system. Similarly, HAI laws in most states included provisions requiring that HAI data be publicly reported (Table 3 ).
Device-Associated Infection Data Submission
States varied with regard to data submission requirements for device-associated infections. Most states with HAI laws required that hospitals report CLABSI in adult, pediatric, and neonatal ICUs ( Table 4 ). The majority of those states first required CLABSI data submission in adult ICUs in 2008 and 2009 (56% for both years); in contrast, requirements for CLABSI data submission in pediatric and neonatal ICUs appeared to have occurred in 2 waves, with the largest proportions of those states first requiring data submission in 2008 and 2011 ( Table 5 ). Notably fewer states required CAUTI and VAP data submission (Table 4 ). For those states with CAUTI data submission requirements, most began in 2012 (Table 5 ).
MDRO Infection Data Submission
States also varied with regard to requirements for MDRO infections. About half of states with HAI laws required that hospitals submit MRSA and/or C difficile infection data (Table 4 ). However, only 3 states (8%) required vancomycin-resistant enterococci data submission (Table 4 ). There was no clear period during which most states with HAI laws first required MDRO infection reporting; however, among those states with MRSA and C difficile requirements, the largest proportions first required data submission in 2013 ( Table 5 ).
Discussion
HAI Data Submission Requirements
The results presented here show that, as of January 31, 2013, 37 states and territories (71%) had enacted legislation and/or promulgated administrative regulations requiring data submission for at least 1 type of HAI. These findings build on previous work showing that, as of August 1, 2011, 32 states had mandatory data submission requirements. 7 Four states recently implemented those requirements; 2 of those states (Arkansas and New Mexico) previously had only voluntary data submission. This increase in the number of states with mandatory reporting reflects an environment of increased data submission and public reporting requirements throughout the nation. Furthermore, the study team tracked the development of state mandates and submission requirements over time and found many states requiring data submission for multiple device-associated infections, as well as infections caused by MRSA, vancomycin-resistant enterococci, and C difficile. Note that despite having HAI laws, neither Florida nor Puerto Rico required acute care hospitals to submit data congruent with the infections discussed here.
Trends in HAI Laws and HAI Program Implementation
Most states with HAI laws first enacted them in 2006 and 2007 (54% for both years), and most HAI laws became effective those same years (52% for both years); this trend reflected evidence that emerged in the previous decade emphasizing the importance of HAIs. For example, the Institute of Medicine's 1999 publication To Err Is Human 8 was instrumental in publicizing that HAIs were not only a leading cause of morbidity and mortality 
Laws
States and Territories (n = 52) No. (%)   Yes  AL, AR, CA, CO, CT, DC, DE, FL, GA, HI, IL, IN, MA, MD, ME, MN, MO, NC, NH, NJ, NM, NV,  NY, OH, OK, OR, PA, PR, RI, SC, TN, TX, UT, VA, VT, WA, WV   37 (71)   No  AK, AZ, IA, ID, KS, KY, LA, MI, MS, MT, ND, NE, SD, WI, WY 15 (29) among hospitalized patients in the United States but also largely preventable. Additional reports 9,10 highlighting that HAI, specifically CLABSI, could be prevented, along with the publication of a guidance document to assist in the design and implementation of HAI reporting systems, 11 were important drivers of the development of state-level HAI laws across the country at that time.
In 2009, funding from the American Recovery and Reinvestment Act provided $40 million to 49 states, the District of Columbia, and Puerto Rico for the purposes of developing, expanding, and supporting HAI program infrastructure in those states, as well as monitoring and preventing HAIs. The Act's funding affected those states enacting legislation and promulgating administrative regulations starting in 2009 and going forward. It also likely affected the timing of when HAI programs were established. Despite the majority of states first enacting HAI legislation in 2006 and 2007, it was not until 2008 and 2009 that most states with HAI laws implemented an HAI prevention program (60%). There was a similar lag between statute enactment and when most states first required hospitals to submit HAI data. These observed lags likely were not just a function of funding availability but also a reflection of the time necessary to hire staff, establish the HAI programs, and appoint an HAI advisory committee. Of note, in 7 states HAI program implementation predated statutory requirements for HAI reporting, thereby indicating that some states were proactive in starting their HAI prevention efforts in the absence of a legal mandate.
Trends in Specific HAI Reporting
The data presented here demonstrate that, among states with HAI laws, most first required that CLABSI data be submitted by hospitals, with the majority beginning in 2008 and 2009. In fact, reporting of other device-associated infections, as well as infections caused by MDROs, tended not to occur until several years later. CLABSI reporting likely preceded reporting of other HAIs in many states because they were identified early on as being common, potentially fatal, expensive, and largely preventable with simple and inexpensive interventions. 10, [12] [13] [14] For states with CAUTI reporting requirements, most began in 2012; for states with MRSA and C difficile reporting requirements, the largest proportions began in 2013. Much of the timing of when states first required that specific HAIs be reported was influenced by the federal Centers for Medicare & Medicaid Services' (CMS') Hospital Inpatient Quality Reporting Program, in which hospitals are required to report HAIs via the NHSN. For instance, acute care hospitals participating in the program were first required to report CAUTI events in January 2012 and MRSA bacteremia and C difficile laboratory-confirmed events in January 2013. This is consistent with when most states required reporting of those same HAIs, as already discussed. This observation is further supported by the period when states required CLABSI reporting in pediatric and neonatal ICUs, 2 waves of which occurred. The second wave, in 2011, aligned with requirements of the CMS (beginning in January 2011) that adult, pediatric, and neonatal ICUs in acute care hospitals report CLABSI events. Overall, these findings suggest that federal reporting requirements have been and may continue to be an important influence on state mandated reporting. Among states with HAI data submission requirements, only 11% required VAP reporting. Note that 2 states (Illinois and Missouri) with statutory requirements for VAP reporting did not submit data. In Missouri, a process measure (head of bed elevation) was substituted for the purposes of public reporting-mainly State and federally mandated HAI reporting has broadened the focus of HAI prevention efforts. Although these mandates are designed to promote patient safety and decrease HAIs, prevention occurs at the facility level, and lack of resources is an issue. HAI prevention efforts in the United States have been built on the efforts of frontline health care epidemiologists and infection preventionists. Although the prominence of their work and the demands on their time have increased dramatically with mandatory reporting, most have not seen corresponding increases in support for their efforts.
Limitations
State-level HAI data reporting requirements provide a unique example of administrative law. Most state HAI statutes grant state departments of health the authority to alter HAI mandates without legislatively amending statutory provisions. As such, although attempts were made to be as thorough as possible in this review, as well as confirm results with HAI coordinators, because of the states' flexibility in changing their mandates, it is possible that a data element is not correct. Furthermore, the legal analysis focused on laws directly applicable to state HAI data submission and public reporting requirements. Other laws not specific to state HAI programs (eg, communicable disease, licensing) were not included in this analysis. In addition, reporting laws relating to community-associated infections (ie, not hospital-associated infections) were not included. Note, however, that HAI mandates in 2 states (New Mexico and Georgia) are in the notifiable disease rule and thus reported via notifiable conditions. Other states have HAIs on their notifiable diseases lists, but, unlike those for New Mexico and Georgia, they are not reported to the NHSN.
Conclusions
These findings demonstrate that, since 2003, the majority of states and territories have adopted laws requiring the reporting of at least 1 HAI to their departments of health, reflecting an environment of increased concern for patient safety across the nation over a relatively short period. Although most states with HAI laws require CLABSI, MRSA, and C difficile reporting, data submission requirements vary across states. Federal mandates may be significant influencers of state HAI law adoption, and this is important to consider when addressing current and emerging HAIs. Recent studies have suggested that HAI reduction efforts at the state 20 or federal level 21 have not achieved their desired effects on hospital infection rates, indicating that other prevention efforts are also at play. Considering the facility and state resources required to comply with HAI reporting mandates, future work should address whether these laws have indeed had the desired impact of reducing infection rates.
